Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Clinical trial NCT04840589 · SUSPENDED

Trial details

NCT number: NCT04840589
Sponsor: National Cancer Institute (NCI)
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Solid Neoplasm Recurrent Malignant Solid Neoplasm Recurrent Platinum-Resistant Ovarian Carcinoma Refractory Ovarian Carcinoma

Start date: 2022-02-02
Primary completion: 2028-09-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.